Targeted therapies in small cell lung cancer (Review)

被引：27

作者：

Lu, Hong-Yang ^{[1
]}

Wang, Xiao-Jia ^{[1
]}

Mao, Wei-Min ^{[1
]}

机构：

[1] Zhejiang Canc Hosp, Zhejiang Key Lab Diag & Treatment Technol Thorac, Hangzhou 310022, Zhejiang, Peoples R China

来源：

ONCOLOGY LETTERS | 2013年 / 5卷 / 01期

关键词：

small cell lung cancer; targeted therapy; epidermal growth factor receptor; vascular endothelial growth factor; apoptosis; gene; GROWTH-FACTOR RECEPTOR; PHASE-II TRIAL; BCL-2 ANTISENSE OLIGONUCLEOTIDE; C-KIT; ADJUVANT VACCINATION; RESPONDING PATIENTS; IMATINIB MESYLATE; EGFR MUTATION; DOUBLE-BLIND; CHEMOTHERAPY;

D O I：

10.3892/ol.2012.791

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Lung cancer is the leading cause of cancer-related mortality. Small cell lung cancer (SCLC) accounted for 12.95% of all lung cancer histological types in 2002. Despite trends toward modest improvement in survival, the outcome remains extremely poor. Chemotherapy is the cornerstone of treatment in SCLC. More than two-thirds of patients who succumb to lung cancer in the United States are over 65 years old. Elderly patients tolerate chemotherapy poorly and need novel therapeutic agents. Targeted drugs have less toxicity than chemotherapy drugs, but no targeted agents have been approved for use in the treatment of SCLC patients to date. Certain new targeted agents, including gefitinib, bevacizumab and Bcl-2 inhibitors, offer a promise of improved outcomes, however negative results are more commonly reported than positive. This review focuses on targeted therapies in SCLC.

引用

页码：3 / 11

页数：9

共 50 条

[31] Targeted Therapies for Non-Small Cell Lung Cancer: An Evolving Landscape [J].

Pal, Sumanta Kumar ;

Figlin, Robert A. ;

Reckamp, Karen .

MOLECULAR CANCER THERAPEUTICS, 2010, 9 (07) :1931-1944

[32] Novel targeted therapies for advanced non-small lung cancer [J].

Abughanimeh, Omar ;

Kaur, Anahat ;

El Osta, Badi ;

Ganti, Apar Kishor .

SEMINARS IN ONCOLOGY, 2022, 49 (3-4) :326-336

[33] Update on targeted therapies for small cell carcinoma of the lung [J].

Richard W. Griffiths ;

Paul Lorigan ;

Nicholas Thatcher ;

Fiona H. Blackhall .

Targeted Oncology, 2008, 3

[34] Update on targeted therapies for small cell carcinoma of the lung [J].

Griffiths, Richard W. ;

Lorigan, Paul ;

Thatcher, Nicholas ;

Blackhall, Fiona H. .

TARGETED ONCOLOGY, 2008, 3 (03) :205-215

[35] Therapies in the pipeline for small-cell lung cancer [J].

Romanidou, Ourania ;

Imbimbo, Martina ;

Mountzios, Giannis ;

Abidin, Aidalena ;

Morgillo, Floriana ;

Califano, Raffaele .

BRITISH MEDICAL BULLETIN, 2016, 119 (01) :37-48

[36] Combination of radiotherapy and targeted therapies in the treatment of locally advanced non-small cell lung cancer [J].

Sacco, Paola Claudia ;

Maione, Paolo ;

Rossi, Antonio ;

Bareschino, Maria Anna ;

Schettino, Clorinda ;

Guida, Cesare ;

Elmo, Massimo ;

Ambrosio, Rita ;

Barbato, Valentina ;

Zeppa, Rosario ;

Palazzolo, Giovanni ;

Gridelli, Cesare .

TARGETED ONCOLOGY, 2011, 6 (03) :171-180

[37] Development of molecularly targeted agents and immunotherapies in small cell lung cancer [J].

Sharp, Adam ;

Bhosle, Jaishree ;

Abdelraouf, Fatma ;

Popat, Sanjay ;

O'Brien, Mary ;

Yap, Timothy A. .

EUROPEAN JOURNAL OF CANCER, 2016, 60 :26-39

[38] Current Targeted Therapies for the Fight against Non-Small Cell Lung Cancer [J].

Mustachio, Lisa Maria ;

Roszik, Jason .

PHARMACEUTICALS, 2020, 13 (11) :1-14

[39] The development of targeted therapy in small cell lung cancer [J].

Zhang, Yalei ;

He, Jianxing .

JOURNAL OF THORACIC DISEASE, 2013, 5 (04) :538-548

[40] Molecularly Targeted Therapies in Locally Advanced Non-Small-Cell Lung Cancer [J].

Devarakonda, Siddhartha ;

Morgensztern, Daniel ;

Govindan, Ramaswamy .

CLINICAL LUNG CANCER, 2013, 14 (05) :467-472

← 1 2 3 4 5 →